Prediction: Rigetti Computing Stock Is Going to Plummet in 2026

Rigetti Computing has fallen about 70% from its all-time high and still trades around $17, with a $5.6 billion market cap that implies more than 50x projected 2028 sales. The article argues the company remains unprofitable, faces heavy dilution, and is under pressure from stronger competitors such as IonQ and QCi. It also highlights insider selling at a 16:1 ratio over the past 12 months and warns the stock could decline further if execution disappoints.

Analysis

The setup is less about near-term fundamentals and more about financing risk meeting narrative fatigue. In pre-revenue frontier tech, the market usually tolerates dilution as long as each capital raise buys a visible step-function in technical credibility; here, the issue is that commercial proof is still lagging the valuation multiple, so every new equity issuance likely accretes less than the prior one. That creates a negative reflexivity loop: weaker stock, higher cost of capital, more dilution, lower per-share claim on the same optionality.

The competitive dynamic is also shifting against the older, cryogenic architecture. Companies with higher-fidelity or less infrastructure-heavy approaches can attract more of the scarce pilot-budget dollars because enterprise buyers are buying a roadmap, not just qubits. That means the likely winner set is not the broad quantum basket, but the names that can convert customer trials into repeatable system deployments faster than the market’s patience window, which is probably measured in quarters rather than years.

The main bullish counterpoint is that this kind of stock can overshoot on both sides: if the company lands even one credible enterprise-scale deployment or a partnership that validates modular scaling, the short thesis becomes crowded quickly. But absent a catalyst in the next 1-2 quarters, the stock remains vulnerable to estimate cuts, secondary offerings, or a broader de-rating of speculative duration assets. The asymmetry is unfavorable because downside can reprice on a financing event while upside requires operational proof that usually takes multiple reporting cycles.

The market is likely underappreciating second-order damage to smaller ecosystem vendors and lab-oriented customers if funding conditions tighten: quantum spend gets pushed out, not cancelled, which hurts order timing more than headline demand. That makes the better trade not a simple directional short on the category, but a relative-value expression versus the most credible platform winner and the least diluted balance sheet.

Key Decisions for Investors

• Short RGTIW or buy put spreads into the next earnings window; target a 3-6 month horizon where any miss or guidance reset can trigger a 20-35% de-rating, with defined risk via premium paid.
• Pair trade: long IONQ / short RGTIW for the next 2 quarters; the trade expresses the market’s preference for higher-fidelity, lower-infrastructure technology and should outperform if enterprise pilots continue to concentrate in the more credible platform.
• Avoid initiating fresh longs in RGTI-equity-linked exposure until after the next capital raise risk passes; dilution is the key hidden variable, and a financing event can compress the stock faster than operating progress can re-rate it.
• For more conservative exposure to quantum optionality, prefer IBM over RGTI on a 6-12 month basis; lower upside, but materially better downside protection if the sector re-rates on execution rather than hype.
• If holding a short, trim into any announcement-driven spike above recent resistance; this name is likely to remain highly headline-sensitive, so the best entry is post-rally or after volume confirmation of failed follow-through.